PLETRICO Trademark

Trademark Overview


On Friday, November 9, 2012, a trademark application was filed for PLETRICO with the United States Patent and Trademark Office. The USPTO has given the PLETRICO trademark a serial number of 85775767. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 20, 2023. This trademark is owned by Glaxo Group Limited. The PLETRICO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardi...
pletrico

General Information


Serial Number85775767
Word MarkPLETRICO
Filing DateFriday, November 9, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 20, 2023
Registration Number4990990
Registration DateTuesday, July 5, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Friday, January 20, 2023CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 5, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 5, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, June 1, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, May 31, 2016NOTICE OF ALLOWANCE CANCELLED
Tuesday, May 31, 2016TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, December 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 14, 2015SOU EXTENSION 5 GRANTED
Wednesday, December 9, 2015SOU EXTENSION 5 FILED
Wednesday, December 9, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 4, 2015SOU EXTENSION 4 GRANTED
Monday, June 1, 2015SOU EXTENSION 4 FILED
Monday, June 1, 2015TEAS EXTENSION RECEIVED
Friday, December 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 4, 2014SOU EXTENSION 3 GRANTED
Thursday, November 20, 2014SOU EXTENSION 3 FILED
Thursday, November 20, 2014TEAS EXTENSION RECEIVED
Thursday, June 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 11, 2014SOU EXTENSION 2 GRANTED
Thursday, May 22, 2014SOU EXTENSION 2 FILED
Tuesday, June 10, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 22, 2014TEAS EXTENSION RECEIVED
Wednesday, December 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 16, 2013SOU EXTENSION 1 GRANTED
Monday, December 16, 2013SOU EXTENSION 1 FILED
Monday, December 16, 2013TEAS EXTENSION RECEIVED
Tuesday, July 2, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 7, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 17, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 29, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 26, 2013ASSIGNED TO LIE
Monday, March 11, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 11, 2013EXAMINER'S AMENDMENT ENTERED
Monday, March 11, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 11, 2013EXAMINERS AMENDMENT E-MAILED
Monday, March 11, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, March 7, 2013ASSIGNED TO EXAMINER
Friday, November 16, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 13, 2012NEW APPLICATION ENTERED